CBIO - Catalyst Biosciences Inc
Close
0.5113
-0.014 -2.719%
Share volume: 483,723
Last Updated: Mon 30 Oct 2023 09:00:00 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.53
-0.01
-2.65%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | |
---|---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | |
Report Date | 2022-05-09 | 2022-08-15 | 2022-11-14 | 2023-03-30 | |
Total revenue | 794.000 K | 0.000 | 0.000 | 0.000 | |
Cost of revenue | 798.000 K | 0.000 | 0.000 | 0.000 | |
Gross profit | -4.000 K | 0.000 | 0.000 | 0.000 | |
100.00% | nan% | nan% | |||
Operating expenses | 14.697 M | 5.715 M | 5.166 M | 4.825 M | |
Selling general and admin | 4.994 M | 3.844 M | 4.363 M | 4.165 M | |
Research and development | 9.703 M | 1.871 M | 803.000 K | 660.000 K | |
Total expenses | 15.495 M | 5.715 M | 5.166 M | 4.825 M | |
-63.12% | -9.61% | -6.60% | |||
Operating income | -14.701 M | -5.715 M | -5.166 M | -4.825 M | |
Ebit | -14.701 M | -5.715 M | -5.166 M | -4.825 M | |
Pretax income | -14.536 M | 51.632 M | -4.884 M | -40.106 M | |
-455.20% | -109.46% | 721.17% | |||
Income tax | 0.000 | 0.000 | 0.000 | 348.000 K | |
Net income basic | -14.536 M | 51.632 M | -4.884 M | -40.454 M | |
455.20% | -109.46% | -728.30% | |||
Net income | -14.536 M | 51.632 M | -4.884 M | -40.454 M | |
455.20% | -109.46% | -728.30% |